Modeling osteosarcoma to identify novel therapeutic targets.
|
Stanford University / Julien Sage |
Young Investigator Grants |
2006 |
California |
Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies |
Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD |
Young Investigator Grants |
2021 |
Ohio |
Enhancing the therapeutic efficacy of chimeric antigen receptor T cells for acute myeloid leukemia |
Washington University / Miriam Kim, MD |
Young Investigator Grants |
2019 |
Missouri |
Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma |
Children’s Hospital of Philadelphia / Kristopher Bosse, MD |
Young Investigator Grants |
2016 |
Pennsylvania |
Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche |
Children’s Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD |
Young Investigator Grants |
2021 |
Pennsylvania |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma |
Children’s Hospital of Philadelphia / Robyn Sussman, PhD |
Young Investigator Grants |
2015 |
Pennsylvania |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies
|
Dana-Farber Cancer Institute / Ujwal Pyati |
Young Investigator Grants |
2009 |
Massachusetts |
Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide
|
University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD |
Young Investigator Grants |
2008 |
Texas |